JLM-Lifetech Co-Authored Technical Code for Acceptance of Laboratory Animal Barrier Facility Environment, Published

On July 17, the "3rd Innovation and Development Seminar on Laboratory Animal Facilities and Equipment Technology & Conference on Laboratory Green Low-Carbon Construction and Smart Equipment Application," hosted by the Laboratory Animal Facility and Equipment Technology Branch of the China Entry-Leave Inspection and Quarantine Association (CIQA), was held in Shanghai. During the conference, the group standard T/CIQA 166-2026 Technical Code for Acceptance of Laboratory Animal Barrier Facility Environment, organized and formulated by CIQA, was officially released. As one of the drafting units of this standard, JLM-Lifetech was invited to attend and honored at the ceremony.

Certificate Awarded to Editorial Committee Members of Technical Code for Acceptance of Laboratory Animal Barrier Facility Environment

Laboratory animal barrier environments serve as critical "infrastructure" for life science research and the biopharmaceutical industry. The quality of their construction directly impacts animal welfare, biosafety, and the reliability of scientific research data. For a long time, the industry faced a common pain point: "benchmarks for design exist, but detailed rules for acceptance are lacking." Once barrier facilities were constructed, there was a lack of actionable group standards to evaluate whether microbiological metrics, environmental factors, and operational states truly met requirements.

The newly released T/CIQA 166-2026, led by CIQA, bridges smoothly with previously developed standards such as Code for Process Design of Laboratory Animal Barrier Facilities. This initiative aims to progressively build a standard matrix where "national standards set the baseline, group standards define the process, and the entire workflow is actionable, verifiable, and monitorable."

Acceptance testing for barrier environments encompasses multi-dimensional evaluations—including air cleanliness, differential pressure, temperature, humidity, as well as microbiological and pathogen metrics. Achieving this requires robust support from molecular biology diagnostic equipment and related inspection/quarantine reagents, which happens to be the core business line JLM-Lifetech specializes in.

JLM-Lifetech Participated in Drafting the Technical Code for Acceptance of Laboratory Animal Barrier Facility Environment

Founded in Chengdu in 2016, JLM-Lifetech is a recognized "SRDI" (Specialized, Refined, Differential, and Innovative) enterprise in Sichuan Province. The company holds over 80 independent intellectual property rights, as well as Class III Medical Device Registration Certificates and Manufacturing Licenses. JLM-Lifetech’s molecular diagnostic equipment and animal inspection/quarantine reagents have long served research institutions, customs/ports of entry, and disease control centers. During the drafting process, JLM-Lifetech contributed practical feedback from an equipment manufacturer's perspective, converting parameters repeatedly validated in real-world applications into baseline references for the standard clauses.

Serving as one of the drafting units for CIQA's standard signifies that JLM-Lifetech’s technical capability and product expertise have earned recognition from a national-level industry association. It also highlights the company’s continuous accumulation in the molecular detection field—extending its reach from "manufacturing products" to "providing reference benchmarks for industry standardization."

Moving from product R&D to collaborative standard building is a milestone rooted in JLM-Lifetech’s deep understanding of testing scenarios. It points toward a clear objective: enabling life science diagnostic equipment to deliver tangible value across standardized scenarios, providing solid foundational support for the high-quality development of the industry.